3M Company v. Ugly Juice, LLC dba Good Use

District Court, N.D. California·Decided April 23, 2021·No. 5:21-cv-02338·Unknown

Opinion

3M COMPANY, Case No. 5:21-cv-02338-EJD Plaintiff, ORDER GRANTING PLAINTIFF’S v. MOTION FOR TEMPORARY RESTRAINING ORDER AND FOR UGLY JUICE, LLC DBA GOOD USE, et ORDER TO SHOW CAUSE RE al., PRELIMINARY INJUNCTION Defendants. Re: Dkt. No. 10

Plaintiff 3M Company (3M) brings this action against Defendants Ugly Juice, LLC dba Good Use, RDGIV Holdings LLC, Grant Carlson, Slava Chupryna, Sabrina Corpus, and Ralph Dewar Gaines (collectively, “Defendants”) for violations of the Lanham Act including trademark counterfeiting, trademark infringement, unfair competition, false endorsement, false designation of origin, trademark dilution, as well as other California statutory and common law violations. 3M’s claims arise from Defendants’ alleged ongoing misconduct and use of 3M’s name and “3M” trademarks to perpetrate false and deceptive offers for sale and sales of counterfeit personal protective equipment (“PPE”) to customers, during the COVID-19 pandemic—without authorization and for inappropriate commercial benefit. Complaint (“Compl.”), Dkt. No. 1 ¶ 1. 3M now seeks a temporary restraining order and preliminary injunction to halt Defendants, and their agents from selling or offering to sell counterfeit 3M-brand N95 respirators. For the reasons below, the Court will grant the temporary restraining order. 3M is a Delaware corporation that manufactures healthcare and safety products for Case No.: 5:21-cv-02338-EJD industries and consumers worldwide. Compl. ¶ 27. As a result of the COVID-19 pandemic, a high demand exists for 3M’s N95 respirator products (N95 masks). To keep them safe while working to mitigate the effects of the pandemic, first responders, healthcare professionals, and other frontline workers depend on 3M’s N95 masks. Id. ¶ 37. In order to meet the rising demand for N95 masks, 3M has increased its annual production of N95 masks to approximately 2 billion. Id. As demand for PPE and in particular N95 masks has increased however, 3M has seen individuals and companies trying to exploit the situation. Id. ¶ 41. To help protect the public and healthcare professionals on the front lines of the COVID-19 pandemic from counterfeiting, misleading and substantially inferior PPE products, to help reduce time and money wasted by government and other procurement officials on scams, and to protect 3M’s goodwill and reputation in its 3M brand, 3M has worked with law enforcement authorities, online e-commerce retailers, and others to combat unethical and unlawful business practices related to 3M-brand N95 masks. Id. ¶ 42. 3M’s efforts are seen on its website, which lists the single case price for the most common models of its 3M-brand N95 masks so that the public can identify and avoid inflated pricing. Id. ¶ 43. In addition, customers of 3M can help identify and report fraud and counterfeiting on its website, which provides several identifiers of counterfeit goods as well as lot numbers known to be associated with counterfeit goods. Id. 3M commenced this trademark-infringement action against Defendants on March 31, 2021. 3M’s complaint alleges that the Defendants are using 3M’s registered trademarks to advertise and sell counterfeit 3M-branded N95 masks. Most notably, 3M alleges that in August 2020, Defendants contacted a Salt Lake City, Utah based elder care group to sell counterfeit 3M Model 1860 and 1860S N95 masks. Id. ¶ 45. In October 2020, the elder care group purchased over 37,000 3M Model 1860 N95 masks for $155,874.00, which were shipped to their facilities. Id. ¶ 46. In February 2021, the elder care group realized that the N95 masks it purchased were not like others that they had previously purchased and contacted 3M’s COVID-19 Fraud Response Case No.: 5:21-cv-02338-EJD Team. Id. ¶ 47. The elder care group provided photos of the products that they purchased, which 3M alleges exhibited signs of counterfeiting as described on 3M’s website. Id. ¶ 48. Specifically, 3M states that the lot numbers (B20522 and B20018) on the masks are known-counterfeit lot numbers and the packaging was inauthentic. Id. ¶ 49; see also Declaration of Christine McCool (“McCool Decl.”), Dkt. No. 10-1 ¶ 14; Exs. 4 and 6. Defendants also charged the elder care group more than three times the single case list price for these counterfeit products. Compl. ¶ 50; McCool Decl. ¶ 13. In December 2020, Defendants also sold thousands of counterfeit 3M-brand N95 masks to a New York hospital. Compl. ¶ 51. The hospital spent $11,741.80 for the counterfeit 3M Model 1860 and 1860S N95 masks. Id. After suspecting the 3M-brand N95 masks they had received were inauthentic, the hospital contacted 3M and provided photographic evidence that 3M alleges demonstrated the hospital had received counterfeit goods from Defendants. Id. ¶¶ 52-53. Specifically, they exhibited several indicia of fraud described on 3M’s website, including the inclusion of known counterfeit lot numbers and inauthentic packaging. Id. ¶ 54. Further, Defendants attempted to sell hundreds of thousands of counterfeit 3M-brand N95 masks to a Seattle, Washington based health care system. Id. ¶ 55; McCool Decl. ¶ 17. Defendants informed the healthcare system that their fulfillment partner on these products was CovCare, Inc. (“CovCare”) and that CovCare was an approved 3M distributor. Id. 3M asserts that CovCare is not an approved distributor and instead, is a Staten Island, New York based company that sells counterfeit 3M-brand N95 masks. Compl. ¶ 56. 3M alleges that Defendants contacted at least five other hospitals and health care systems located across the country, offering to sell hundreds of thousands of counterfeit 3M-brand N95 masks. Id. ¶¶ 58, 61. The hospitals and health care systems each contacted 3M and reported counterfeiting and fraud concerns after the Defendants offered a “proof of life” video, to demonstrate the authenticity and availability of the 3M-brand N95 masks. Id. ¶¶ 60-62. 3M brings nine claims for relief, including five federal claims under the Lanham Act. Case No.: 5:21-cv-02338-EJD 3M’s first and second claims allege that Defendants are engaging in trademark counterfeiting and infringement, in violation of 15 U.S.C. § 1114(1), by using spurious designations on its products that are identical to 3M’s federally registered trademarks. 3M’s third claim alleges that the Defendants are engaging in unfair competition and false designation of origin, in violation of 15 U.S.C. § 1125(a)(1)(A), by creating the false impression that the products they purposed to offer originate from, and/or are sponsored or approved by, and/or offered with authorization from 3M. 3M’s fourth claim alleges that Defendants are engaging in trademark dilution, in violation of 15 U.S.C. § 1125(c), by using 3M’s trademarks in the sale of counterfeit products. 3M’s fifth claim alleges that Defendants are engaging in false advertising, in violation of 15 U.S.C. § 1125(a)(1)(B), by making statements to the general public and medical health professionals that contain false, misleading, and/or deceptive statements about the nature and quality of the products Defendants have for sale. 3M’s remaining four claims allege violations of California’s trademark law and business and professional code. On April 19, 2021, 3M filed the pending motion requesting the Court issue a temporary restraining order, an order to show cause why a preliminary injunction should not issue, and for the opportunity to conduct limited expedited discovery in advance of the hearing on the preliminary injunction. Motion for Temporary Restraining Order and Preliminary Injunction (“Mot.”), D

Free access — add to your briefcase to read the full text and ask questions with AI

3M Company v. Ugly Juice, LLC dba Good Use, (N.D. Cal. 2021).

3M Company v. Ugly Juice, LLC dba Good Use (3M Company v. Ugly Juice, LLC dba Good Use) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related